Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Resource Type
Article
Authors
Gelderblom, Hans ; Jones, Robin L. ; Blay, Jean-Yves ; George, Suzanne ; von Mehren, Margaret ; Zalcberg, John R. ; Kang, Yoon-Koo ; Razak, Albiruni Abdul ; Trent, Jonathan ; Attia, Steven ; Le Cesne, Axel ; Siontis, Brittany L. ; Goldstein, David ; Boye, Kjetil ; Sanchez, Cesar ; Steeghs, Neeltje ; Rutkowski, Piotr ; Druta, Mihaela ; Serrano, César ; Somaiah, Neeta ; Chi, Ping ; Harrow, Brooke ; Becker, Claus ; Reichmann, William ; Sherman, Matthew L. ; Ruiz-Soto, Rodrigo ; Heinrich, Michael C. ; Bauer, Sebastian
Source
In European Journal of Cancer October 2023 192
Subject
Language
ISSN
0959-8049